SB
Stipple Bio, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$65.1Msold at filing
Total offering$100.2M$35.1M still open
Investors in the raise15count reported to the SEC
FiledApr 6, 2026first sale Mar 31, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Vineeta AgarwalaDirector
Greg VerdineDirector
Thilo SchroederDirector
Owen HughesDirector
Aaron RingDirector
Derek DiRoccoDirector
Jeffrey LandauExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.